GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exact Sciences Corp (NAS:EXAS) » Definitions » Cyclically Adjusted PB Ratio

Exact Sciences (Exact Sciences) Cyclically Adjusted PB Ratio : 5.39 (As of May. 01, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Exact Sciences Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Exact Sciences's current share price is $59.71. Exact Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $11.08. Exact Sciences's Cyclically Adjusted PB Ratio for today is 5.39.

The historical rank and industry rank for Exact Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

EXAS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.41   Med: 16.3   Max: 43.88
Current: 5.36

During the past years, Exact Sciences's highest Cyclically Adjusted PB Ratio was 43.88. The lowest was 3.41. And the median was 16.30.

EXAS's Cyclically Adjusted PB Ratio is ranked worse than
83.33% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.975 vs EXAS: 5.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Exact Sciences's adjusted book value per share data for the three months ended in Dec. 2023 was $17.342. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $11.08 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Exact Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Exact Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Sciences Cyclically Adjusted PB Ratio Chart

Exact Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.33 26.81 10.80 5.33 6.68

Exact Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 6.90 9.13 6.35 6.68

Competitive Comparison of Exact Sciences's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Exact Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exact Sciences's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Exact Sciences's Cyclically Adjusted PB Ratio falls into.



Exact Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Exact Sciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=59.71/11.08
=5.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exact Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Exact Sciences's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=17.342/129.4194*129.4194
=17.342

Current CPI (Dec. 2023) = 129.4194.

Exact Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201403 1.709 99.695 2.219
201406 2.929 100.560 3.770
201409 2.587 100.428 3.334
201412 3.261 99.070 4.260
201503 2.904 99.621 3.773
201506 2.525 100.684 3.246
201509 3.751 100.392 4.836
201512 3.381 99.792 4.385
201603 2.950 100.470 3.800
201606 2.538 101.688 3.230
201609 3.342 101.861 4.246
201612 3.042 101.863 3.865
201703 2.784 102.862 3.503
201706 4.542 103.349 5.688
201709 4.408 104.136 5.478
201712 4.319 104.011 5.374
201803 5.637 105.290 6.929
201806 6.071 106.317 7.390
201809 5.832 106.507 7.087
201812 5.527 105.998 6.748
201903 6.019 107.251 7.263
201906 5.918 108.070 7.087
201909 5.764 108.329 6.886
201912 15.499 108.420 18.501
202003 16.980 108.902 20.179
202006 16.743 108.767 19.922
202009 15.542 109.815 18.317
202012 14.023 109.897 16.514
202103 21.303 111.754 24.670
202106 20.710 114.631 23.382
202109 20.074 115.734 22.448
202112 19.506 117.630 21.461
202203 18.560 121.301 19.802
202206 18.152 125.017 18.791
202209 17.538 125.227 18.125
202212 17.104 125.222 17.677
202303 17.003 127.348 17.280
202306 16.930 128.729 17.021
202309 17.262 129.860 17.203
202312 17.342 129.419 17.342

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Exact Sciences  (NAS:EXAS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Exact Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Exact Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Exact Sciences (Exact Sciences) Business Description

Traded in Other Exchanges
Address
5505 Endeavor Lane, Madison, WI, USA, 53719
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Executives
Brian Baranick officer: Gen. Mgr., Precision Oncology 441 CHARMANY DRIVE, MADISON WI 53719
Sarah Condella officer: SVP, Human Resources 441 CHARMANY DRIVE, MADISON WI 53719
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Everett Cunningham officer: Chief Commercial Officer C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Jeffrey Thomas Elliott officer: Chief Financial Officer 5505 ENDEAVOR LANE, MADISON WI 53719
James Edward Doyle director 5505 ENDEAVOR LANE, MADISON WI 53719
James Herriott officer: General Counsel 5505 ENDEAVOR LANE, MADISON WI 53719
Katherine S Zanotti director 431 E 9TH STREET, HINSDALE IL 60521
Jacob A Orville officer: General Manager, New Ventures 5505 ENDEAVOR LANE, MADISON WI 53719
Kevin T Conroy director, officer: Vice President 5505 ENDEAVOR LANE, MADISON WI 53719
D Scott Coward officer: SVP and General Counsel 441 CHARMANY DRIVE, MADISON WI 53719
Paul J Clancy director C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Graham Peter Lidgard officer: SVP, Chief Scientific Officer 5505 ENDEAVOR LANE, MADISON WI 53719
Michael S Wyzga director RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, CAMBRIDGE MA 02139
Torsten Hoof officer: General Manager, International 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063